Detalhe da pesquisa
1.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682738
2.
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
Support Care Cancer
; 31(7): 425, 2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358628
3.
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
Oncologist
; 27(10): e783-e795, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124924
4.
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Oncologist
; 27(12): e949-e956, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920559
5.
Renal cell carcinoma: the population, real world, and cost-of-illness.
BMC Urol
; 22(1): 206, 2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36536329
6.
Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators.
J Transl Med
; 19(1): 328, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344414
7.
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).
Oncology
; 99(12): 747-755, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34583356
8.
Fatal hyperprogression induced by nivolumab in metastatic renal cell carcinoma with sarcomatoid features: a case report.
Anticancer Drugs
; 32(2): 222-225, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32868643
9.
Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer.
Support Care Cancer
; 28(10): 4687-4695, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960124
10.
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients.
Br J Clin Pharmacol
; 85(6): 1283-1289, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30740760
11.
Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacy.
Anticancer Drugs
; 26(4): 469-73, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25569703
12.
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib.
Clin Genitourin Cancer
; 22(2): 514-522.e1, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296678
13.
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients.
Ther Adv Urol
; 16: 17562872241244574, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38638242
14.
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.
Sci Rep
; 14(1): 4949, 2024 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418470
15.
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study.
Eur Urol
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521617
16.
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
Clin Genitourin Cancer
; : 102074, 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616147
17.
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations.
Clin Exp Metastasis
; 41(2): 117-129, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363410
18.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410103
19.
Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: A case report and review of the literature.
Front Oncol
; 13: 1136300, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959812
20.
Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinoma.
Tumori
; 109(6): 562-569, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37501595